Q4 2024 Management View CEO Roger Susi highlighted record Q4 2024 performance with $19.4M in revenue, marking the 14th consecutive record quarter. He emphasized the continued strong demand for IV ...

Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

Reports Q4 revenue $19.4M vs $17.5M last year. “We are proud to close out 2024 with another record-breaking quarter, marking our fourteenth ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

On January 22, 2025, the Lions Club of Penetanguishene presented a cheque for $5,200 to Victoria Evans, community Giving ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory path for Onapgo has been marked by ...

Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...

MRI-Compatible IV Infusion Pump Systems MarketThe global market for MRI-compatible IV infusion pump systems is set for significant expansion, driven by advancements in medical imaging and increasing ...

Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical utilization rising, ...

These medications come with significant limitations, especially in the later stages of the disease, which can be listed as follows: Infusion therapy for Parkinson’s disease (PD) involves the ...

EL CENTRO — On Monday, El Centro city officials broke ground on the Southern Pump Station, a critical infrastructure project located at Dannenberg Road poised to revolutionize El Centro’s wastewater ...